Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 61 Similar Profiles
Natural Killer Cells
Medicine & Life Sciences
Graft vs Host Disease
Medicine & Life Sciences
Fetal Blood
Medicine & Life Sciences
Cell Transplantation
Medicine & Life Sciences
KIR Receptors
Medicine & Life Sciences
Transplants
Medicine & Life Sciences
Transplantation
Medicine & Life Sciences
Interleukin-15
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1996 2024
Cancer Center Support Grant
Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, B. A., Peterson, L. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/19 → 1/31/24
Project: Research project
Neoplasms
Next Generation TriKE Development: EpCAM, otherTriKEs
Miller, J. S., Felices, M. & Vallera, D. A.
10/1/16 → 12/31/19
Project: Research project
Epithelial Cell Adhesion Molecule
myeloid leukemia
natural killer cells
NK Cells, Their Receptors, Transplantation and Cancer Th
Miller, J. S., Cooley, S. A., Ho, Y., Le, C. T., Luo, X., Tolar, J., Vallera, D. A., Verneris, M. R. & Weisdorf, D. J.
NIH NATIONAL CANCER INSTITUTE (NCI)
4/5/16 → 3/31/21
Project: Research project
Natural Killer Cell Receptors
Transplantation
Neoplasms
Therapeutics
Biology and Transplantation of the Hematopoietic Stem Cell
Wagner, J. E., Blazar, B. R., Brunstein, C. G., Cooley, S. A., De For, T. E., Hippen, K. L., Le, C. T., Lindgren, B. R., Luo, X., McKenna, D. H., Miller, J. S., Pennell, C. A., Stefanski, H. E., Tolar, J. & Verneris, M. R.
NIH NATIONAL CANCER INSTITUTE (NCI)
9/25/15 → 8/31/20
Project: Research project
Hematopoietic Stem Cell Transplantation
Research Output 1991 2019
Assessing canonical and adaptive natural killer cell function in suppression assays in vitro
Sarhan, D. & Miller, J. S., Jan 1 2019, Methods in Molecular Biology. Humana Press Inc., p. 153-166 14 p. (Methods in Molecular Biology; vol. 1913).Research output: Chapter in Book/Report/Conference proceeding › Chapter
Natural Killer Cells
Regulatory T-Lymphocytes
Cytomegalovirus
Neoplasms
Coculture Techniques
2
Citations
(Scopus)
Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells
Uppendahl, L. D., Felices, M., Bendzick, L., Ryan, C., Kodal, B., Hinderlie, P., Boylan, K. L., Skubitz, A. P., Miller, J. S. & Geller, M. A., Apr 1 2019, In : Gynecologic oncology. 153, 1, p. 149-157 9 p.Research output: Contribution to journal › Article
Natural Killer Cells
Ovarian Neoplasms
Cytokines
Immunosuppressive Agents
Ascites
Donor Killer Cell Immunoglobulin-Like Receptor Genotype Does Not Improve Graft-versus-Leukemia Responses in Chronic Lymphocytic Leukemia after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis
Bachanova, V., Weisdorf, D. J., Wang, T., Marsh, S. G. E., Cereb, N., Haagenson, M. D., Spellman, S. R., Lee, S. J., Guethlein, L. A., Parham, P., Miller, J. S. & Cooley, S. A., May 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 5, p. 949-954 6 p.Research output: Contribution to journal › Article
KIR Receptors
Unrelated Donors
B-Cell Chronic Lymphocytic Leukemia
Leukemia
Bone Marrow
Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
Erbe, A. K., Wang, W., Carmichael, L., Hoefges, A., Grzywacz, B. J., Reville, P. K., Ranheim, E. A., Hank, J. A., Kim, K. M., Seo, S., Mendonca, E. A., Song, Y., Kenkre, V. P., Hong, F., Gascoyne, R. D., Paietta, E., Horning, S. J., Miller, J. S., Kahl, B. & Sondel, P. M., Mar 12 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 70.Research output: Contribution to journal › Article
Open Access
KIR Receptors
Follicular Lymphoma
Ligands
Genotype
Natural Killer Cells
3
Citations
(Scopus)
KIR Donor Selection: Feasibility in Identifying better Donors
the participating center writing committee, Jan 1 2019, In : Biology of Blood and Marrow Transplantation. 25, 1, p. e28-e32Research output: Contribution to journal › Article
Donor Selection
Immunoglobulins
Tissue Donors
Transplants
Acute Myeloid Leukemia